NCT04585425 is a NA clinical trial of Sleep hygiene advice in Insomnia, sponsored by University of Aarhus.

Who is sponsoring NCT04585425?

NCT04585425 is sponsored by University of Aarhus.

What drugs are being tested in NCT04585425?

Interventions in NCT04585425: Sleep hygiene advice, Bedtime music listening.

Is NCT04585425 still recruiting?

NCT04585425 is currently completed. Last updated 20 December 2023.

Last reviewed 2023-12-20 · How we verify

NCT04585425

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Music for Sleep-onset Insomnia

Completed NA Last updated 20 December 2023

What this trial tests

NA trial testing Sleep hygiene advice in Insomnia in 60 participants. Completed in 2 June 2023.

Timeline

1 May 2021

Primary endpoint
10 April 2023

2 June 2023

Quick facts

Lead sponsor	University of Aarhus
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	1 May 2021
Primary completion	10 April 2023
Estimated completion	2 June 2023
Sites	1 location across Denmark

Drugs / interventions tested

Sleep hygiene advice
Bedtime music listening

Conditions studied

Insomnia — all drugs for Insomnia →

Sponsor

University of Aarhus

Who can join

Adults 18 to 65, any sex, with Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a randomized controlled trial evaluating the effect of bedtime music as an early intervention for sleep-onset insomnia in adults. The investigators use a randomized controlled trial design with two parallel groups. All participants receive sleep hygiene advice as standard treatment and participants in the intervention group are additionally asked to listen to a sleep playlist daily at bedtime. Subjective and objective sleep measures are evaluated before and after the 4 weeks intervention period. In addition, follow-up measures of subjective outcomes are assessed 4 weeks after the end of the intervention period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Listening to music for insomnia in adults.
Jespersen KV, Pando-Naude V, Koenig J, Jennum P, et al · · 2022 · cited 28× · PMID 36000763 · DOI 10.1002/14651858.cd010459.pub3

Verify or expand the search:

Other recruiting trials for Insomnia

Currently open trials in the same condition.

NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04585425 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 20 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04585425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing